The blockbuster success of the GLP-1 agonists and related drugs has renewed interest in peptide-based therapeutics, but how is the manufacturing technology evolving? 

In the latest episode of the DCAT Value Chain Insights podcast, Production to Prescription, a roundtable of industry experts share their perspectives on the latest in peptide synthesis.  

Solid-phase peptide synthesis (SPPS) is the dominant method in peptide synthesis, but other approaches, such as liquid-phase peptide synthesis (LPPS) and hybrid approaches are being used. Industry experts share how these approaches are being deployed and their benefits and limitations as well as innovation in peptide synthesis, including continuous manufacturing and enzymatic ligation. 

Participating in the roundtable were Alaric Desmarchelier, PhD, Business Development Manager, Peptides, Almac Sciences; Mimoun Ayoub, PhD, Senior Vice President and Global Commercial Head of Peptides, CordenPharma; Matt Bio, PhD, Chief Scientific Officer, Cambrex; and Eric Fang, PhD, General Manager, Snapdragon Chemistry, Cambrex. 

DCAT Value Chain Insights’ Production to Prescription podcast features thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance. ICYMI, other recent episodes include: 

What Tops the Industry’s Sustainability Agenda for 2026?, featuring Dr. Ute Schleyer, Vice President, Internal Project Management and EHS Sustainability, Vetter; 

2026 Outlook: CDMO Market for Injectables, featuring Ian Tzeng, Managing Director and Partner, L.E.K. Consulting and lead of L.E.K.’s Pharmaceutical Contract Services Practice; and  

2026: Drugs To Watch: The Year Ahead, featuring Matthew Arnold, Principal Analyst, Clarivate. 

Each episode of the Production to Prescription podcast is housed on the DCAT Value Chain Insights website and also delivered through DCAT Value Chain Insights weekly email digest. Not a subscriber? Click here to subscribe to DCAT Value Chain Insights or get each episode through 

The 2026 schedule for the Production to Prescription podcast may be found here.